Human germline and somatic cells have similar TP53 and Kirsten-RAS gene single base mutation frequencies

Environmental and Molecular Mutagenesis

Volumn 49, Issue 6, 2008, Pages 417-425

  Cole, Derek N ^a   Carlson, J Andrew ^b   Wilson, Vincent L ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Germline mutation frequencies; Human sperm; KRAS; Single base substitution mutations; TP53

Indexed keywords

PROTEIN P53;

ARTICLE; CELL VIABILITY; CLINICAL ARTICLE; CONCEPTION; DISEASE ASSOCIATION; EMBRYO DEVELOPMENT; GERM LINE; HUMAN; HUMAN CELL; MALE; MUTATION RATE; ONCOGENE K RAS; POLYMERASE CHAIN REACTION; PREVALENCE; PROGENY; SOMATIC CELL; SPERM; WILD TYPE;

DNA MUTATIONAL ANALYSIS; GENE FREQUENCY; GERM-LINE MUTATION; HUMANS; LIGASE CHAIN REACTION; MALE; MUTATION; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RESTRICTION MAPPING; SPERMATOZOA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 48249128289     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.20390     Document Type: Article

References (59)

1. Backvall H, Asplund A, Gustafsson A, Sivertsson A, Lundeberg J, Ponten F. 2005. Genetic tumor archeology: Microdissection and genetic heterogeneity in squamous and basal cell carcinoma. Mutat Res 571:65-79.
2. Baumgartner A, Schmid TE, Maerz HK, Adler ID, Tarnok A, Nuesse M. 2001. Automated evaluation of frequencies of aneuploid sperm by laser-scanning cytometry (LSC). Cytometry 44:156-160.
3. Bendig I, Mohr N, Kramer F, Weber BH. 2004. Identification of novel TP53 mutations in familial and sporadic cancer cases of German and Swiss origin. Cancer Genet Cytogenet 154:22-26.
4. Brandriff BF, Gordon LA, Carrano AV. 1990. Cytogenetics of human sperm: Structural aberrations and DNA replication. Prog Clin Biol Res B 340:425-434.
5. Brown, JL. 1999. N-Nitrosamines. Occup Med (Philadelphia, Pa) 14:839-848.
6. Cerutti P, Hussain P, Pourzand C, Aguilar F. 1994. Mutagen of the H-ras protooncogene and the p53 tumor suppressor gene. Cancer Res 54:1934s-1938s.
7. Cho C, Jung-Ha H, Willis WD, Goulding EH, Stein P, Xu Z, Schultz RM, Hecht NB, Eddy EM. 2003. Protamine 2 deficiency leads to sperm DNA damage and embryo death in mice. Biol Reprod 69:211-217.
8. Cooper DN, Krawczak M. 1990. The mutational spectrum of single base-pair substitutions causing human genetic disease: Patterns and predictions. Hum Genet 85:55-74.
9. Cordelli E, Eleuteri P, Leter G, Rescia M, Spano M. 2005. Flow cytometry applications in the evaluation of sperm quality: Semen analysis, sperm function and DNA integrity. Contraception 72:273-279.
10. Crow JF. 2000. The origins, patterns and implications of human spontaneous mutation. Nat Rev Genet 1:40-47.
11. Crow, JF. 2006. Age and sex effects on human mutation rates: An old problem with new complexities. J Radiat Res (Tokyo) 47 (Suppl B):B75-B82.
12. Drost JB, Lee WR. 1995. Biological basis of germline mutation: Comparisons of spontaneous germline mutation rates among drosophila, mouse, and human. Environ Mol Mutagen 26:48-64.
13. Glaser RL, Broman KW, Schulman RL, Eskenazi B, Wyrobek AJ, Jabs EW. 2003. The paternal-age effect in Apert syndrome is due, in part, to the increased frequency of mutations in sperm. Am J Hum Genet 73:939-947.
14. Goriely A, McVean GA, Rojmyr M, Ingemarsson B, Wilkie AO. 2003. Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line. Science 301:643-646.
15. Goriely A, McVean GA, van Pelt AM, O'Rourke AW, Wall SA, de Rooij DG, Wilkie AO. 2005. Gain-of-function amino acid substitutions drive positive selection of FGFR2 mutations in human spermatogonia. Proc Natl Acad Sci USA 102:6051-6056.
16. Halliday GM. 2005. Inflammation, gene mutation and photoimmunosuppression in response to UVR-induced oxidative damage contributes to photocarcinogenesis. Mutat Res 571:107-120.
17. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100:57-70.
18. Hassold T, Hunt P. 2001. To err (meiotically) is human: The genesis of human aneuploidy. Nat Rev Genet 2:280-291.
19. Hassold T, Hall H, Hunt P. 2007. The origin of human aneuploidy: Where we have been, where we are going. Hum Mol Genet 16 (Spec No.2):R203-R208.
20. Hussain SP, Amstad P, Raja K, Ambs S, Nagashima M, Bennett WP, Shields PG, Ham AJ, Swenberg JA, Marrogi AJ, Harris CC. 2000a. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: A cancer-prone chronic inflammatory disease. Cancer Res 60:3333-3337.
21. Hussain SP, Raja K, Amstad PA, Sawyer M, Trudel LJ, Wogan GN, Hofseth LJ, Shields PG, Billiar TR, Trautwein C, Hohler T, Galle PR, Phillips DH, Markin R, Marrogi AJ, Harris CC. 2000b. Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: Oxyradical overload diseases. Proc Natl Acad Sci USA 97:12770-12775.
22. Kalousek DK, Pantzar T, Tsai M, Paradice B. 1993. Early spontaneous abortion: Morphologic and karyotypic findings in 3,912 cases. Birth Defects Orig Artic Ser 29:53-61.
23. Kratz CP, Niemeyer CM, Zenker M. 2007a. An unexpected new role of mutant Ras: Perturbation of human embryonic development. J Mol Med 85:223-231.
24. Kratz CP, Steinemann D, Niemeyer CM, Schlegelberger B, Koscielniak E, Kontny U, Zenker M. 2007b. Uniparental disomy at chromosome 11p15.5 followed by HRAS mutations in embryonal rhabdomyosarcoma: Lessons from Costello syndrome. Hum Mol Genet 16:374-379.
25. Lauritsen JG. 1975. The significance of oral contraceptives in causing chromosome anomalies in spontaneous abortions. Acta Obstet Gynecol Scand 54:261-264.
26. Lijinsky W. 1999. N-Nitroso compounds in the diet. Mutat Res 443:129-138.
27. Loeb LA, Loeb KR, Anderson JP. 2003. Multiple mutations and cancer. Proc Natl Acad Sci USA 100:776-781.
28. Magewu AN, Jones PA. 1994. Ubiquitous and tenacious methylation of the CpG site in codon 248 of the p53 gene may explain its frequent appearance as a mutational hot spot in human cancer. Mol Cell Biol 14:4225-4232.
29. Marchetti F, Wyrobek AJ. 2005. Mechanisms and consequences of paternally-transmitted chromosomal abnormalities. Birth Defects Res C Embryo Today 75:112-129.
30. Meistrich, ML. 1993. Effects of chemotherapy and radiotherapy on spermatogenesis. Eur Urol 23:136-141; discussion 142.
31. Nachman MW, Crowell SL. 2000. Estimate of the mutation rate per nucleotide in humans. Genetics 156:297-304.
32. Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P. 2002. The IARC TP53 database: New online mutation analysis and recommendations to users. Hum Mutat 19:607-614.
33. Olivier M, Goldgar DE, Sodha N, Ohgaki H, Kleihues P, Hainaut P, Eeles RA. 2003. Li-Fraumeni and related syndromes: Correlation between tumor type, family structure, and TP53 genotype. Cancer Res 63:6643-6650.
34. Pasteur X, Metezeau P, Maubon I, Sabido O, Kiefer H. 1994. Identification of two human sperm populations using flow and image cytometry. Mol Reprod Dev 38:303-309.
35. Peterson SK, Pentz RD, Blanco AM, Ward PA, Watts BG, Marani SK, James LC, Strong LC. 2006. Evaluation of a decision aid for families considering p53 genetic counseling and testing. Genet Med 8:226-233.
36. Qin J, Calabrese P, Tiemann-Boege I, Shinde DN, Yoon SR, Gelfand D, Bauer K, Arnheim N. 2007. The molecular anatomy of spontaneous germline mutations in human testes. PLoS Biol 5:e224.
37. Rubes J, Vozdova M, Robbins WA, Rezacova O, Perreault SD, Wyrobek AJ. 2002. Stable variants of sperm aneuploidy among healthy men show associations between germinal and somatic aneuploidy. Am J Hum Genet 70:1507-1519.
38. Rudak E, Jacobs PA, Yanagimachi R. 1978. Direct analysis of the chromosome constitution of human spermatozoa. Nature 274:911-913.
39. Rydberg B, Lindahl T. 1982. Nonenzymatic methylation of DNA by the intracellular methyl group donor S-adenosyl-L-methionine is a potentially mutagenic reaction. EMBO J 1:211-216.
40. Schmid TE, Brinkworth MH, Hill F, Sloter E, Kamischke A, Marchetti F, Nieschlag E, Wyrobek AJ. 2004. Detection of structural and numerical chromosomal abnormalities by ACM-FISH analysis in sperm of oligozoospermie infertility patients. Hum Reprod 19: 1395-1400.
41. Selby PB. 1998. Major impacts of gonadal mosaicism on hereditary risk estimation, origin of hereditary diseases, and evolution. Genetica 102/103:445-462.
42. Selby PB, Earhart VS, Garrison EM, Raymer GD. 2004. Description of first germinal mosaic mutation identified in dominant skeletal mutation experiments and considerations about how to deal with this kind of spontaneous mutation in analyses. Mutat Res 545:109-115.
43. Seril DN, Liao J, Yang GY, Yang CS. 2003. Oxidative stress and ulcerative colitis-associated carcinogenesis: Studies in humans and animal models. Carcinogenesis 24:353-362.
44. Shelby MD, Bishop JB, Mason JM, Tindall KR. 1993. Fertility, reproduction, and genetic disease: Studies on the mutagenic effects of environmental agents on mammalian germ cells. Environ Health Perspect 100:283-291.
45. Sloter ED, Lowe X, Moore ID, Nath J, Wyrobek AJ. 2000. Multicolor FISH analysis of chromosomal breaks, duplications, deletions, and numerical abnormalities in the sperm of healthy men. Am J Hum Genet 67:862-872.
46. Sloter ED, Marchetti F, Eskenazi B, Weldon RH, Nath J, Cabreras D, Wyrobek AJ. 2007. Frequency of human sperm carrying structural aberrations of chromosome 1 increases with advancing age. Fertil Steril 87:1077-1086.
47. Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, Abeysinghe S, Krawczak M, Cooper DN. 2003. Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat 21:577-581.
48. Tapp RA, Feng J, Jones JW, Carlson JA, Wilson VL. 2007. Single base instability is promoted in vulvar lichen sclerosus. J Invest Dermatol 127:2563-2576.
49. Tiemann-Boege I, Navidi W, Grewal R, Cohn D, Eskenazi B, Wyrobek AJ, Arnheim N. 2002. The observed human sperm mutation frequency cannot explain the achondroplasia paternal age effect. Proc Natl Acad Sci USA 99:14952-14957.
50. Tommerup N. 1993. Mendelian cytogenetics. Chromosome rearrangements associated with mendelian disorders. J Med Genet 30:713-727.
51. Varley JM. 2003. Germline TP53 mutations and Li-Fraumeni syndrome. Hum Mutat 21:313-320.
52. Wiederkehr C, Basavaraj R, Sarrauste de Menthiere C, Hermida L, Koch R, Schlecht U, Amon A, Brachat S, Breitenbach M, Briza P, Caburet S, Cherry M, Davis R, Deutschbauer A, Dickinson HG, Duinitrescu T, Fellous M, Goldman A, Grootegoed JA, Hawley R, Ishii R, Jegou B, Kaufman RJ, Klein F, Lamb N, Maro B, Nasmyth K, Nicolas A, Orr-Weaver T, Philippsen P, Pineau C, Rabitsch KP, Reinke V, Roest H, Saunders W, Schroder M, Schedl T, Step M, Villeneuve A, Wolgemuth DJ, Yamamoto M, Zickler D, Esposito RE, Primig M. 2004. GermOnline, a cross-species community knowledge-base on germ cell differentiation. Nucleic Acids Res 32:D560-D567.
53. Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE, Armstrong EG, Nisula BC. 1988. Incidence of early loss of pregnancy. N Engl J Med 319:189-194.
54. Wilson VL. 2001. Detecting rare mutations associated with cancer risk. Am J Pharmacogenomics 1:283-293.
55. Wilson VL, Wei Q, Wade KR, Chisa M, Bailey D, Kanstrup CM, Yin X, Jackson CM, Thompson B, Lee WR. 1999. Needle-in-a-haystack detection and identification of base substitution mutations in human tissues. Mutat Res 406:79-100.
56. Wilson VL, Yin X, Thompson B, Wade KR, Watkins JP, Wei Q, Lee WR. 2000. Oncogenic base substitution mutations in circulating leukocytes of normal individuals. Cancer Res 60:1830-1834.
57. Wilson VL, Wade KR, Yin X, Albertini RJ. 2001. Temporal delineation of sequential HPRT mutations arising in vivo in a T-cell clone with a mutator phenotype. Mutat Res 473:181-199.
58. Wyrobek AJ, Eskenazi B, Young S, Arnheim N, Tiemann-Boege I, Jabs EW, Glaser RL, Pearson FS, Evenson D. 2006. Advancing age has differential effects on DNA damage, chromatin integrity, gene mutations, and aneuploidies in sperm. Proc Natl Acad Sci USA 103:9601-9606.
59. Zhang Y, Monckton DG, Siciliano MJ, Connor TH, Meistrich ML. 2002. Detection of radiation and cyclophosphamide-induced mutations in individual mouse sperm at a human expanded trinucleotide repeat locus transgene. Mutat Res 516:121-138.